"We are pleased to bring additional MedMira rapid tests to our customers in Mainland China and Hong Kong. The multiple test for drugs of abuse will be the first of its kind in this market and answer a growing demand for reliable and fast drug tests," said Yiu Ming Fung, President and Chairman of Triplex. "We look forward to further expanding our partnership with MedMira in the near future with a focus on the co-development of new rapid tests for cancer and heart disease markers."